SCHEMBL24200423

SCHEMBL24200423

CCc1nccc2c3cc(OC)ccc3n(C(=O)c3ccccc3)c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
TSHR P16473 1/20 0.55
NFKB1 P19838 1/20 0.55
HIF1A Q16665 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
PLA2G2A P14555 1/20 0.53
AKR1C3 P42330 4/20 0.52
ELANE P08246 1/20 0.51
PTGS2 P35354 2/20 0.48
PTGS1 P23219 1/20 0.48
AKR1C2 P52895 3/20 0.48
HASPIN Q8TF76 1/20 0.47
AKR1C4 P17516 1/20 0.47
AKR1C1 Q04828 1/20 0.47
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
PPARG P37231 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24200394 0.88 BCHE (0.59) LMNACYP1A2CYP2D6CYP2C9TSHR
SCHEMBL20158842 0.87 LMNA (0.53) LMNACYP1A2CYP2D6CYP2C9TSHR
SCHEMBL20135910 0.78 LMNA (0.56) LMNACYP1A2CYP2D6CYP2C9TSHR
SCHEMBL12949361 0.77 LMNA (0.80) LMNACYP1A2CYP2D6CYP2C9TSHR
SCHEMBL20158833 0.76 LMNA (0.54) LMNACYP1A2CYP2D6CYP2C9TSHR
SCHEMBL20158976 0.75 LMNA (0.52) LMNACYP1A2CYP2D6CYP2C9TSHR
SCHEMBL20139098 0.73 LMNA (0.55) LMNACYP1A2CYP2D6CYP2C9TSHR
SCHEMBL23391007 0.72 LMNA (0.83) LMNACYP1A2CYP2D6CYP2C9TSHR
SCHEMBL1082631 0.71 HIF1A (1.00) LMNACYP1A2CYP2D6CYP2C9TSHR
SCHEMBL20135890 0.71 AKR1C3 (0.53) LMNACYP1A2CYP2D6CYP2C9HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538529-B1 SELECTIVE INHIBITORS OF GENOTOXIC STRESS-INDUCED IKK/NF-KB PATHWAYS MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT (DE) 2022-01-19 EP disclosed